Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Asthma

Recruiting

Registered drugNo placebo

Safety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study

Registered drugNo placebo

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Benralizumab

Contact Research Centre

Narcolepsy

Recruiting

Investigational

Efficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Alks 2680

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:SPY002

Contact Research Centre

Narcolepsy

Recruiting

Investigational

Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Alks 2680

Contact Research Centre

Narcolepsy

Recruiting

Investigational

Phase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Alks 2680

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

A Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:SPY002

Contact Research Centre

Uveal melanoma

Recruiting

InvestigationalNo placebo

A Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Darovasertib

Contact Research Centre

Cardiovascular disorder+1

Recruiting

Investigational

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:ZILEBESIRAN

Contact Research Centre

Migraine

Recruiting

Registered drug

Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins

Contact Research Centre

Migraine

Recruiting

Registered drug

Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins

Contact Research Centre

Vitiligo

Recruiting

Investigational

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Investigational

Austria

Participants:0–17 years
Substances:Ruxolitinib

Contact Research Centre

Find therapies in clinical trials near you

362 trials match your criteria

Asthma

Safety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study

Narcolepsy

Efficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1

Colitis ulcerative

Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Narcolepsy

Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2

Narcolepsy

Phase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1

Non-small cell lung cancer+1

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Colitis ulcerative

A Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis

Uveal melanoma

A Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread

Cardiovascular disorder+1

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Migraine

Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

Migraine

Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

Vitiligo

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.